Back to Search Start Over

Assessing atypical brain functional connectivity development: An approach based on generative adversarial networks.

Authors :
Dos Santos PMN
Mendes SL
Biazoli C
Gadelha A
Salum GA
Miguel EC
Rohde LA
Sato JR
Source :
Frontiers in neuroscience [Front Neurosci] 2023 Jan 09; Vol. 16, pp. 1025492. Date of Electronic Publication: 2023 Jan 09 (Print Publication: 2022).
Publication Year :
2023

Abstract

Generative Adversarial Networks (GANs) are promising analytical tools in machine learning applications. Characterizing atypical neurodevelopmental processes might be useful in establishing diagnostic and prognostic biomarkers of psychiatric disorders. In this article, we investigate the potential of GANs models combined with functional connectivity (FC) measures to build a predictive neurotypicality score 3-years after scanning. We used a ROI-to-ROI analysis of resting-state functional magnetic resonance imaging (fMRI) data from a community-based cohort of children and adolescents (377 neurotypical and 126 atypical participants). Models were trained on data from neurotypical participants, capturing their sample variability of FC. The discriminator subnetwork of each GAN model discriminated between the learned neurotypical functional connectivity pattern and atypical or unrelated patterns. Discriminator models were combined in ensembles, improving discrimination performance. Explanations for the model's predictions are provided using the LIME (Local Interpretable Model-Agnostic) algorithm and local hubs are identified in light of these explanations. Our findings suggest this approach is a promising strategy to build potential biomarkers based on functional connectivity.<br />Competing Interests: LAR has received grant or research support from, served as a consultant to, and served on the speakers’ bureau of Abbott, Aché, Bial, Medice, Novartis/Sandoz, Pfizer/Upjohn, and Shire/Takeda in the last three years. The ADHD and Juvenile Bipolar Disorder Outpatient Programs chaired by LAR have received unrestricted educational and research support from the following pharmaceutical companies in the last three years: Novartis/Sandoz and Shire/Takeda. LAR has received authorship royalties from Oxford Press and ArtMed. All of these are outside of the study. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The handling editor declared a past co-authorship with the author JS.<br /> (Copyright © 2023 Dos Santos, Mendes, Biazoli, Gadelha, Salum, Miguel, Rohde and Sato.)

Details

Language :
English
ISSN :
1662-4548
Volume :
16
Database :
MEDLINE
Journal :
Frontiers in neuroscience
Publication Type :
Academic Journal
Accession number :
36699518
Full Text :
https://doi.org/10.3389/fnins.2022.1025492